Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

University of North Carolina-Chapel Hill

Superfund Research Program

DNA Adducts as Biomarkers of Exposure and Effect

Project Leader: James A. Swenberg
Grant Number: P42ES005948
Funding Period: 1995-2018

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Project Summary (2000-2006)

This project is focusing on development of sound scientific understanding of the mode of action and the observed and expected dose response relationship of several of the major hazardous chemicals on the National Priority List. These data are suitable for use with the 1996 Revised Cancer Risk Assessment Guidelines and are improving the accuracy of risk assessments. Project investigators have hypothesized that several aliphatic and aromatic chlorinated hydrocarbons share an important mode of action referred to as "oxidative stress." Through this mechanism, Reactive Oxygen Species (ROS) cause damage to DNA and activate signal transduction pathways involved in gene regulation and cell proliferation. This research is identifying the most useful biomarkers of oxidative stress and examining the extent and type of oxidative stress-related damage to DNA and proteins that are produced by NPL chemicals. These biomarkers are being examined in human blood samples of individuals with known concentrations of PCBs.

Back
to Top